Data di Pubblicazione:
2013
Abstract:
Nonsteroidal anti-inflammatory drugs (NSAIDs) are nowadays widely used in ophthalmology to reduce eye inflammation, pain,
and cystoid macular edema associated with cataract surgery. Recently, new topical NSAIDs have been approved for topical
ophthalmic use, allowing for greater drug penetration into the vitreous. Hence, new therapeutic effects can be achieved, such as
reduction of exudation secondary to age-related macular degeneration or diabetic maculopathy.We provide an updated review on
the clinical use of NSAIDs for retinal diseases, with a focus on the potential future applications.
and cystoid macular edema associated with cataract surgery. Recently, new topical NSAIDs have been approved for topical
ophthalmic use, allowing for greater drug penetration into the vitreous. Hence, new therapeutic effects can be achieved, such as
reduction of exudation secondary to age-related macular degeneration or diabetic maculopathy.We provide an updated review on
the clinical use of NSAIDs for retinal diseases, with a focus on the potential future applications.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
macular edema; Topical Nonsteroidal Anti-Inflammatory Drugs
Elenco autori:
Russo, Andrea; Costagliola, C; Delcassi, L; Parmeggiani, F; Romano, Mr; Dell'Omo, R; Semeraro, Francesco
Link alla scheda completa:
Pubblicato in: